Abstract
The feasibility of skin penetration was studied for aspalatone (AM, acetylsalicylic acid maltol ester), a novel antithrombotic agent. In this study, hairless mouse dorsal skins were used as a model to select composition of vehicle and AM. Based on measurements of solubility and partition coefficient, the concentration of PG that showed the highest flux for AM across the hairless mouse skin was found to be 40%. The cumulative amount permeated at 48 h, however, appear inadequate, even when the PG concentration was employed. To identify a suitable absorption enhancer and its optimal concentration for AM, a number of absorption enhancers and a variety of concentration were screened for the increase in transdermal flux of AM. Amongst these, linoleic acid (LOA) at the concentration of 5% was found to have the largest enhancement factor (i.e., 132). However, a further increase in AM flux was not found in the fatty acid concentration greater than 5%, indicating the enhancement effect is in a bell-shaped curve. In a study of the effect of AM concentration on the permeation, there was no difference in the permeation rate between 0.5 and 1% for AM, below its saturated concentration. At the donor concentration of 2%, over the saturated condition, the flux of AM was markedly increased. A considerable degradation of AM was found during permeation studies, and the extent was correlated with protein concentrations in the epidermal and serosal extracts, and skin homogenates. In rat dorsal skins, the protein concentration decreased in the rank order of skin homogenate > serosal extract > epidermal extract. Estimated first order degradation rate constants were 6.15±0.14, 0.57 ±0.02 and 0.011 ±0.004 h-1 for skin homogenate, serosal extract and epidermal extract, respectively. Therefore, it appeared that AM was hydrolyzed to some extent into salicylmaltol by esterases in the dermal and subcutaneous tissues of skin. Taken together, our data indicated that transdermal delivery of AM is feasible when the combination of PG and LOA is used as a vehicle. However, since AM is not metabolically stable, acceptable degradation inhibitors may be necessary to fully realize the transdermal delivery of the drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Aungst, B. J., Rogers, N. J., and Shelter, E., Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides.Int. J. Pharm., 33, 225–234 (1986).
Aungst, B. J., Blake, J. A., and Hussain, M. A., Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines.Pharm. Res., 7, 712–718 (1990).
Awtry, E. H. and Loscalzo, J., Aspirin [cardiovascular drug].Circulation, 101, 1206–1218 (2000).
Barry, B. W., Mode of action of penetration enhancers in human skin.J. Contr. Res., 6, 85–97 (1987).
Chun, I. K. and Gwak, H. S., Permeation and enzymatic degradation of aspalatone in gastrointestinal tract of rabbit.J. Kor. Pharm. Sci., 31, 27–35 (2001).
Cooper, E. R. (1982), Effect of decylmethylsulfoxide on skin penetration. In K. L. Mittal and E. J. Fendler (Eds.). Solution Behavior of Surfactants. Vol. 2. Plenum Press. New York.
Gwak, H. S. and Chun, I. K., Preformulation study of aspalatone, a new antithrombotic agent.J. Appl. Pharm., 8, 332–337 (2000).
Gordon, G. S., Moses, A. C., Silver, R. D., Flier, J. S., and Carey, M. C., Nasal absorption of insulin: enhancement by hydrophobic bile salts.Proc. Natl. Acad. Sci., 82, 7419–7423 (1985).
Han, B. H., Suh, D. Y., Yang, H. O., Park, Y. H., Kang, Y. H., and Kim, Y. C., Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.Arzneim. Forsch., 44, 1122–1126 (1994).
Hirai, S., Yashiki, T., and Mima, H., Mechanisms for the enhancement of the nasal absorption of insulin by surfactants.Int. J. Pharm., 9, 165–172 (1981).
Kitagawa, S., Endo, J. and Kametani, F., Effects of longchaincis-unsaturated fatty acids and their alcohol analogues on aggregation of bovine platelets and their relation with membrane fluidity change.Biochim. Biophys. Acta., 818, 391–397 (1985).
Levang, A. K., Zhao, K., and Singh, J., Effect of ethanol/ propylene glycol on thein vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin.Int. J. Pharm., 181, 255–263 (1999).
Loll, P. J., Picot, D., and Garavito, R. M., The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase.Nat. Struct. Biol., 2, 637–643 (1995).
Nomura, H., Fusao, K., Sugimoto, Y., Miyashita, Y., Dohi, M., and Kato, Y., Percutaneous absorption of indomethacin from mixtures of fatty alcohol and propylene glycol (FAPG bases) through rat skin: effects of oleic acid added to FAPG base.Chem. Pharm. Bull., 38, 1421–1424 (1990).
Ostrenga, J., Steinmetz, C. and Poulsen, B., Significanceof vehicle composition I: Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.J. Pharm. Sci., 60, 1175–1179 (1971).
Patrignani, P., Filabozzi, P., and Patrono, C., Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.J. Clin. Invest., 69, 1366–1372 (1982).
Patrono, C., Aspirin as an antiplatelet drug.N. Eng. J. Med., 330, 1287–1294 (1994).
Roth, G. J. and Majerus, P. W., The mechanism of the effect of aspirin on human platelets I: acetylation of a particulate fraction protein.J. Clin. Invest., 56, 524–632 (1975).
Scheuplein, R. and Ross, L., Effects of surfactants and solvents on the permeability of epidermis,J. Soc. Cosmet. Chem., 21, 853–873 (1970).
Schosinsky, K. H., Vargas, M., Esquivel, A. L., and Chavarria, M.A., Simple spectrophotometric determination of urinary albumin by dye-binding with use of bromophenol blue.Clin. Chem., 33, 223–226 (1987).
Suh, D. Y., Han Y. N., and Han, B. H., Maltol, an antioxidant component of Korean red ginseng, shows little prooxidant activity.Arch. Pharm. Res., 19, 112–115 (1996).
Tengamnuay, P. and Mitra, A. K., Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II.In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa.Pharm. Res., 7, 370–375 (1990).
Yamada, M., Uda, Y., and Tanigawara, Y., Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid.Chem. Pharm. Bull., 35, 3399–3406 (1987).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gwak, H.S., Chun, I.K. Effect of vehicles and enhancers on thein vitro skin penetration of aspalatone and its enzymatic degradation across rat skins. Arch Pharm Res 24, 572–577 (2001). https://doi.org/10.1007/BF02975168
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02975168